Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
[cholangiocarcinoma]
Cyclophilin
A
(
CypA
)
was
shown
to
be
upregulated
in
human
cholangiocarcinoma
(
CCA
)
tissues
.
Suppression
of
intracellular
CypA
(
inCypA
)
significantly
reduces
cell
proliferation
in
vitro
and
tumor
growth
in
nude
mice
.
In
the
present
study
,
the
effect
and
potential
mechanism
of
secreted
CypA
(
sCypA
)
on
cell
proliferation
of
CCA
cell
lines
were
further
investigated
.
CCA
cells
were
treated
with
sCypA-containing
conditioned
media
(
CM
)
or
with
purified
recombinant
human
CypA
(
rhCypA
)
.
Cell
proliferation
,
cell
cycle
,
ERK
1
/
2
,
p
38
MAPK
,
NF-κB
,
Â
and
STAT
3
activities
were
examined
by
MTS
assay
,
flow
cytometry
,
and
Western
blot
.
sCypA
was
detected
in
CM
from
MMNK
1
(
an
immortalized
human
cholangiocyte
cell
line
)
and
six
CCA
cell
lines
.
The
sCypA
levels
corresponded
to
the
inCypA
levels
indicating
the
intracellular
origin
of
sCypA
.
Both
sCypA-containing
CM
and
rhCypA
significantly
increased
proliferation
of
CCA
cells
.
CD
14
7
depletion
by
shRNA-knockdown
or
neutralizing
with
a
CD
14
7
-
monoclonal
antibody
significantly
reduced
sCypA-
,
and
rhCypA-mediated
cell
proliferation
.
Upon
rhCypA
treatment
,
ERK
1
/
2
was
rapidly
phosphorylated
;
whereas
neutralizing
CD
14
7
inhibited
ERK
1
/
2
phosphorylation
.
Cell
cycle
analysis
showed
a
significant
increase
in
S
phase
and
decrease
in
G
1
population
in
rhCypA-treated
cells
.
The
expression
levels
of
cyclin
D
1
and
phosphorylated-
retinoblastoma
protein
in
the
rhCypA-treated
cells
were
increased
compared
with
those
in
the
non-treated
control
cells
.
p
38
MAPK
pathway
was
shown
to
be
suppressed
in
siCypA-treated
cells
.
In
summary
,
CypA
is
secreted
from
CCA
cells
and
enhances
cell
proliferation
in
an
autocrine
/
paracrine
manner
,
at
least
via
direct
binding
with
CD
14
7
,
which
may
activate
the
ERK
1
/
2
and
p
38
MAPK
signaling
pathways
.
Diseases
Validation
Diseases presenting
"immortalized human cholangiocyte cell line"
symptom
cholangiocarcinoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom